One caller during Monday's "Lightning Round" segment of Mad Money asked Jim Cramer about Bionano Genomics (BNGO) : "Buy this one for speculation and only for speculation," said Crarmer about the company that provides a platform to analyze the long segments of genomic DNA and other biomolecules structural variations. Heady stuff.
More from Investing
These recently downgraded names are displaying both quantitative and technical deterioration.
My investment conclusion and strategy is to sell in June for the anticipated market swoon.
A combination of behavioral and financial goals will help you produce exceptional results.
Following many years of big growth-stock gains and low inflation, some are dismissing credible risks much too easily.